?

        當前位置:對照品 > 實驗試劑 > 生化試劑 >
        噴昔洛韋,≥99%
        ??【編號】:125160

        ??【產品名稱】:噴昔洛韋,≥99%

        ??【規格】:50MG

        ??【用途】:

          噴昔洛韋,≥99%

          Product Name: Penciclovir
          別名:6H-Purin-6-one, 2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)butyl]-
          CAS號:39809-25-1
          分子式:C10H15N5O3
          分子量:253.26
          介紹: Penciclovir
          貯存: 儲存溫度-20°C
          可溶性:
          DMSO 34 mg/mL
          Water 1 mg/mL
          Ethanol <1 mg/mL
          生化和生理學機理:
          Description: IC50 Value: 2.3±0.8 mg/ml(EC50, inhibition EBV DNA synthesis); >100mg/ml(50% cell growth inhibitory concentration of both P3HR-1 and Raji cells) Penciclovir, a novel acyclic nucleoside analogue, has demonstrated efficacy against HSV types 1 and 2 and seems to have a pharmacological advantage due to a prolonged half-life of its active form in HSV-infected cells[1]. in vitro: Treatment with GCV or PCV induced rapid accumulation of cells in S-phase and apoptotic death, GCV (and to a lesser extent PCV) increased phosphatidyl serine translocation, induced positive TUNEL results with alterations in cell morphology, caused marked propidium iodide staining and induced DNA laddering. [2]. B-95-8 cells were treated with penciclovir or aciclovir at 1 and 10 ug/ml for 7 days, At 1 ug/ml, both compounds were inactive, but at 10 ug/ml, the virus yield relative to that of untreated virus controls was reduced by 94 and 86% by penciclovir and aciclovir, respectively[5]. in vivo: Penciclovir pharmacokinetics following oral administration of famciclovir were nonlinear within the dosage range studied, likely because of saturation of famciclovir metabolism[3]. Treatment with penciclovir (intravenous formulation) was associated with the development of resistant HSV in only one severely immunocompromised patient (day 7 isolate IC(50) = 2.01 microg/ml), although treatment was effective and resulted in the complete clearance of the lesion by day 8. No patients receiving topical penciclovir developed treatment-associated penciclovir-resistant HSV[4]. Clinical trial: A Comparative Study of the Efficacy of Penciclovir 10 mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers. Phage4
        點擊查看產品價格
        上一篇:Vortioxetine, ≥98% 下一篇:帕洛諾司瓊



          ?
          首 頁 | 對照品| 標準品| 標準物質| 實驗試劑| 培養基| 菌種購買| 新聞中心| 聯系我們| 網站地圖

          2011-2018 北京萊耀生物版權所有豫ICP備17046142號

          ? 主站蜘蛛池模板: 正安县| 永平县| 萨迦县| 定兴县| 华蓥市| 化德县| 安岳县| 秀山| 泌阳县| 南雄市| 子长县| 威宁| 综艺| 樟树市| 资溪县| 白朗县| 满洲里市| 太保市| 肥西县| 汝城县| 广平县| 新安县| 南木林县| 黔西| 卢龙县| 乐至县| 丹阳市| 大荔县| 安远县| 德令哈市| 宜兰市| 象山县| 鲁甸县| 呼玛县| 桂林市| 宽城| 东丽区| 巩留县| 汤阴县| 井陉县| 彭阳县|